| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |